Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05827224 · ClinicalTrials.gov registry record
Air Optix Daily Wear Contact Lenses
A clinical trial of Refractive Errors, sponsored by Alcon Research.
- Completed
- Registry status
- 312
- Enrollment target
- 5
- Study locations
NCT05827224: Completed study of Refractive Errors, sponsored by Alcon Research.
NCT05827224 is a study of Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 312 participants, above the 85-participant average among 14 other Refractive Errors trials with a reported enrollment target (267% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05827224, a study of Refractive Errors, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 312 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as daily wear.
Primary Outcome
The subject's chart will be reviewed for distance visual acuity at baseline and at 1 year following the baseline exam.
Conditions Studied
Interventions
- DEVICE Lotrafilcon B spherical soft contact lenses
- DEVICE Lotrafilcon B spherical soft contact lenses with comfort additive
- DEVICE Lotrafilcon B toric soft contact lenses with comfort additive
- DEVICE Comfilcon A spherical soft contact lenses
- DEVICE Comfilcon A toric soft contact lenses
Study Locations (5)
Florida
- Vision Health Institute - Orlando
Minnesota
- Complete Eye Care of Medina - Medina
Missouri
- Koetting Associates - St Louis
Tennessee
- Toyos Clinic - Nashville
Utah
- Smith Bowman Ophthalmology - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2024-07-17 |
What the finished NCT05827224 record still lists
NCT05827224 is an observational study that tracks outcomes without assigning an intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, above the 85-participant average among 14 other Refractive Errors trials with a reported enrollment target (267% higher).
The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 5 interventions - of which Lotrafilcon B spherical soft contact lenses is the first listed.
NCT05827224 lists 5 locations in 5 states (Florida, Minnesota, Missouri).
Frequently Asked Questions
What is clinical trial NCT05827224 about?
NCT05827224 is a clinical study titled "Air Optix Daily Wear Contact Lenses". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix Aqua, Air Optix plus HydraGlyde Sphere, and Air Optix plus HydraGlyde Toric soft contact lenses in a real-world setting when worn as daily wear.
What is the current status of trial NCT05827224?
This trial is currently completed. The enrollment target is 312 participants. The study started on 2023-08-02. Estimated completion is 2024-07-17.
What conditions does trial NCT05827224 study?
This clinical trial studies the following conditions: Refractive Errors.
What interventions are being tested in trial NCT05827224?
The interventions under investigation include: Lotrafilcon B spherical soft contact lenses (DEVICE), Lotrafilcon B spherical soft contact lenses with comfort additive (DEVICE), Lotrafilcon B toric soft contact lenses with comfort additive (DEVICE), Comfilcon A spherical soft contact lenses (DEVICE), Comfilcon A toric soft contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05827224?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05827224 being conducted?
This trial has 5 study locations across Florida, Minnesota, Missouri, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05827224's enrollment target sits among peer trials
312 2nd of 14 the highest of 14 other Refractive Errors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Refractive Errors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
To Study the Effects of Refractive Surgery on OCT Measurements in the Eye
RECRUITING
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
COMPLETED · NA
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI